Proteomics

Dataset Information

0

Targeting phosphorylation of 17β-hydroxysteroid dehydrogenase 13 at serine 33 to treat nonalcoholic steatohepatitis


ABSTRACT: 17β-hydroxysteroid dehydrogenase-13 (17β-HSD13) is a liver-rich lipid droplet associated protein, encoding by gene HSD17B13, that acted as an important regulator of hepatic lipid metabolism. Increased expression of 17β-HSD13 promotes hepatic lipid accumulation in rodents, and a common loss-of-function variant of HSD17B13 (rs72613567: TA) is related to better outcome in patients with various chronic liver diseases. To understand the role of 17β-HSD13 in liver lipid metabolism under normal and high-fat feeding conditions, we characterized the effect of protein phosphorylation of 17β-HSD13 on hepatic lipid homeostasis. We identify Ser33 as an important protein kinase A (PKA)-mediated phosphorylation site of 17β-HSD13 that physically interact with ATGL and facilitates its translocation to lipid droplets to enhance lipolysis. Mutation of Ser33 to Ala (S33A) in 17β-HSD13 reduces ATGL-dependent lipolysis and increases lipid droplet size in cultured hepatocytes by reducing CGI-58-mediated ATGL activation. Consistently, a transgenic knock-in mouse strain carrying HSD17B13 S33A mutation (HSD17B1333A/A) spontaneously develops liver steatosis with reduced lipolysis. Moreover, HSD17B1333A/A mice are more prone to high fat-induced hepatic steatosis and inflammation. Finally, we found Reproterol, a potential HSD17B13 modulator and FDA-approved drug, confers a protection against liver steatosis possibly through phosphorylation of 17β-HSD13 at Ser33 in a PKA-dependent manner. In summary, we demonstrate a critical role and the underlying mechanism of hepatic 17β-HSD13 phosphorylation in the pathogenesis of NAFLD. Our findings highlight the potential of targeting 17β-HSD13 phosphorylation as a novel therapeutic approach for NAFLD.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell

DISEASE(S): Non-alcoholic Steatohepatitis

SUBMITTER: Rongfeng Lan  

LAB HEAD: Wen Su

PROVIDER: PXD037262 | Pride | 2023-03-11

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
20210826-LRF1.mgf Mgf
20210826-LRF1.mzid.gz Mzid
20210826-LRF1.raw Raw
DB_search_psm.csv Csv
Protein_Gel.pdf Pdf
Items per page:
1 - 5 of 10
altmetric image

Publications


17β-hydroxysteroid dehydrogenase-13 is a hepatocyte-specific, lipid droplet-associated protein. A common loss-of-function variant of HSD17B13 (rs72613567: TA) protects patients against non-alcoholic fatty liver disease with underlying mechanism incompletely understood. In the present study, we identify the serine 33 of 17β-HSD13 as an evolutionally conserved PKA target site and its phosphorylation facilitates lipolysis by promoting its interaction with ATGL on lipid droplets. Targeted mutation o  ...[more]

Similar Datasets

2021-03-11 | PXD021969 | Pride
2024-04-12 | GSE260582 | GEO
2024-04-12 | GSE260581 | GEO
2018-09-25 | GSE89157 | GEO
2020-07-08 | GSE139015 | GEO
2020-05-26 | PXD013423 | Pride
2024-01-31 | GSE248320 | GEO
2024-01-31 | GSE248319 | GEO
2024-01-31 | GSE248317 | GEO
2024-11-01 | GSE236832 | GEO